See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516479_2014_Insys_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516479, Insys Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 82,150,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,127,000 |
| 3 | remainder_Assets | 8,281,000 |
| 4 | LiabilitiesCurrent | 21,081,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 12,665,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,372,000 |
| 9 | ResearchAndDevelopmentExpense | 8,499,000 |
| 10 | remainder_Expenses | 20,394,000 |
| 11 | remainder_Revenues | 99,289,000 |
| 12 | remainder_NetIncome | -982,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,558,000 |
| 1 | Liabilities | 21,081,000 |
| 2 | Expenses | 57,930,000 |
| 3 | Revenues | 99,289,000 |
| 4 | StockholdersEquity | 79,477,000 |
| 5 | NetIncome | 40,377,000 |
| 6 | ComprehensiveNetIncome | 40,377,000 |
| 7 | BaseVar | 139,920,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.51 |
| 9 | EconomicCapitalRatio | 4.04 |